The company Materialise has opened a new production facility for 3D-printed medical implants in the USA. The Michigan facility specializes in custom titanium skull implants, which were previously only manufactured in Belgium.
To date, these implants have been manufactured exclusively in Belgium. With the start-up of the U.S. plant, Materialise can now respond more quickly to surgeons requirements and significantly shorten the delivery time for these special implants.
“With the opening of our new metal 3D printing center in the US, we bring personalized care closer to US patients,” said Brigitte de Vet, Vice President Medical at Materialise. “The power of 3D printing, paired with our three decades of experience in 3D planning and medical manufacturing, allows us to accelerate the delivery of personalized medical implants. We take pride in leading the charge to revolutionize patient-specific care, and with our dedicated facility in Michigan, we further enhance personalized care in the United States.”
In recent years, technologies such as 3D printing have been shown to have a significant impact on personalized patient care. 3D-printed, patient-specific medical solutions, such as anatomical models or surgical guides, offer greater accuracy and efficiency. They help surgeons feel more comfortable before and during surgery, leading to more predictable and precise surgical outcomes.
With more than 30 years of experience in medical solutions, Materialise produces 280,000 personalized 3D-printed instruments and implants annually, 160,000 of which are destined for the U.S. market. The company has introduced numerous breakthrough medical 3D printing applications and continues to reaffirm Materialise’s commitment to innovation in personalized medicine through its latest expansion in the US.